Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (379) Hemophilia
...CenterWatch: Clinical Trials in Category (379) Hemophilia Hemophilia State • California • Michigan • New York California Duarte : City of Hope New! Hemophilia Inhibitor Genetics Study ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (379), Hemophilia
...CenterWatch: New Medical Therapies in Disease Category (379), Hemophilia Hemophilia Patient Medical Areas • Hematology August 29, 2005 Baxter Healthcare reported positive results from a multi ...
View Page

3.  Study Posting (2246) Trial #53827, Hemophilia, Duarte, CA
...Study Posting (2246) Trial #53827, Hemophilia, Duarte, CA Trial Information Hemophilia Inhibitor Genetics Study You have/your child has been asked to ...
View Page

4.  Study Posting (2246) Trial #126213, Hemophilia, Duarte, CA
...Study Posting (2246) Trial #126213, Hemophilia, Duarte, CA Trial Information Universal Data & Serum Specimen Collection System for Hemophilia Subject : You have/Your ...
View Page

5.  Study Posting (2348) Trial #94810, Hemophilia, New York, NY
...Study Posting (2348) Trial #94810, Hemophilia, New York, NY Trial Information Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate rAHF PFM ...
View Page

6.  Study Posting (2348) Trial #87660, Hemophilia, New York, NY
...Study Posting (2348) Trial #87660, Hemophilia, New York, NY Trial Information Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate rAHF PFM ...
View Page

7.  Study Posting (2246) Trial #46328, Hemophilia, Duarte, CA
...Study Posting (2246) Trial #46328, Hemophilia, Duarte, CA Trial Information Long Term Venous Access Catheters and Infection in Hemophilia You have/your ...
View Page

8.  Study Posting (2246) Trial #46322, Hemophilia, Duarte, CA
...Study Posting (2246) Trial #46322, Hemophilia, Duarte, CA Trial Information An International, Randomized, Controlled Trial of Immune-Tolerance Induction Your child is ...
View Page

9.  Study Posting (2246) Trial #162617, Hemophilia, Duarte, CA
...Study Posting (2246) Trial #162617, Hemophilia, Duarte, CA Trial Information Randomised Study of First TIME Immunotolerance Induction in Patients with Severe Type ...
View Page

10.  Study Posting (2246) Trial #158847, Hemophilia, Duarte, CA
...Study Posting (2246) Trial #158847, Hemophilia, Duarte, CA Trial Information Immune Tolerance Induction Study in Patients with Severe Type A Haemophilia with ...
View Page

11.  Study Posting (3489) Trial #105881, Hemophilia, Detroit, MI
...Study Posting (3489) Trial #105881, Hemophilia, Detroit, MI Trial Information Pain in the bleeding disorders community National Pain Study: A call to ...
View Page

12. Clinical Trial Results by Drug Names
...and efficacy of Pegylated interferon alfa 2 a (Peg-IFN) with Ribavirin in Patients with Hemophilia A and Chronic Hepatitis C Fast Facts: Protocol number: ML16814 Sponsor: Hoffmann-La Roche Company division ...
View Page

13.  Newly Approved Drug Therapies (229) BeneFIX (coagulation Factor IX (recombinant)), Genetics Institute,
...BeneFIX (coagulation Factor IX (recombinant)) Company: Genetics Institute Approval Status: Approved February 1997 Treatment Area: hemophilia B General Information BENEFIX, Coagulation Factor IX (Recombinant), has been approved as the first recombinant blood ...
View Page

14.  Newly Approved Drug Therapies (1033) Kogenate FS (Antihemophilic Factor Recombinant), Bayer,
...Name: Kogenate FS (Antihemophilic Factor Recombinant) Company: Bayer Approval Status: Approved June 2000 Treatment Area: hemophilia A General Information Kogenate FS is a new formulation of recombinant factor VIII formulated with sucrose ...
View Page

15.  Study Posting (2246) Trial #126215, Sickle Cell Disease, Duarte, CA
...126215, Sickle Cell Disease, Duarte, CA Trial Information Universal Data & Serum Specimen Collection System for Hemophilia Subject : City of Hope 1500 East Duarte Road Duarte, CA 91010-3000 Phone: 866-896-HOPE ...
View Page

16.  Newly Approved Drug Therapies (201) BeneFIX (coagulation Factor IX (recombinant)), Genetics Institute,
...Factor IX (recombinant)) Company: Genetics Institute Approval Status: Recommended for approval December 1996 Treatment Area: hemophilia B General Information BeneFIX, Coagulation Factor IX (Recombinant) has been approved as the first recombinant blood ...
View Page

17.  CenterWatch: Health Associations For Hematology
...York NY 10001 USA Phone: (212) 328-3712 Fax: (212) 328-3777 E-Mail: handi@hemophilia.org http://www.hemophilia.org The National Hemophilia Foundation is dedicated to finding better treatments and ...
View Page

18.  Study Posting (2246) Trial #140344, Sickle Cell Disease, Duarte, CA
...the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Subjects with Severe Hemophilia A Receiving Prophylaxix and On Demand Treatment Regimens You have/your son has been asked to ...
View Page

19.  Newly Approved Drug Therapies (145) AlphaNine SD Coagulation Factor IX (Human), Alpha Therapeutic Corporation,
...Coagulation Factor IX (Human) Company: Alpha Therapeutic Corporation Approval Status: Approved July 1996 Treatment Area: Hemophilia B General Information AlphaNine SD Coagulation Factor IX (Human) has been approved for the prevention and ...
View Page

20. CenterWatch: Health and Educational Resources
...Fax: (818) 487-7455 (818) 487-7454 theIMF@myeloma.org www.myeloma.org The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to ...
View Page